University of Virginia Cancer Center Joins CancerLinQ® as Participating Practice
ALEXANDRIA, Va. – CancerLinQ LLC, a wholly owned nonprofit subsidiary of the American Society of Clinical Oncology (ASCO®), has announced that the University of Virginia (UVA) Cancer Center has signed an agreement to participate in the CancerLinQ® platform.
“As CancerLinQ® continues to rapidly grow, we are thrilled to have the University of Virginia Cancer Center join our network of oncology practices,” said CancerLinQ LLC CEO Kevin Fitzpatrick. “This large academic large institution will be a great ally in our goal of improving cancer care through aggregating and analyzing patient records.”
CancerLinQ® is a powerful platform containing growing amounts of real-world cancer information. This national initiative will allow cancer providers to improve the quality and value of care by analyzing millions of cancer patient medical records, uncovering patterns and trends, and measuring their care against that of their peers and recommended guidelines.
UVA Cancer Center, a National Cancer Institute (NCI)-designated cancer center, is one of many academic medical centers to join the CancerLinQ® initiative. To date, over 75 practices in 40 states, representing more than 1,500 oncologists, have signed agreements to participate in CancerLinQ. To see the full list of practices currently participating, visit http://cancerlinq.org/care-team.
CancerLinQ® is supported in part through the Conquer Cancer Foundation, whose generous donors have helped make the system possible. Major supporters include Amgen; Astellas; AstraZeneca; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Cancer Treatment Centers of America®; Chan Soon-Shiong Family Foundation; Genentech BioOncology™; HELSINN; Janssen Oncology; Lilly; Raj Mantena, RPh; Novartis Oncology; Pfizer Oncology; Thomas G. Roberts, Jr., MD, and Susan M. DaSilva; and Susan G. Komen®.
CancerLinQ® is a project of CancerLinQ LLC. For more information, please visit CancerLinQ.org.
Founded in 1964, the American Society of Clinical Oncology, Inc. (ASCO®) is committed to making a world of difference in cancer care. As the world’s leading organization of its kind, ASCO represents more than 40,000 oncology professionals who care for people living with cancer. Through research, education, and promotion of the highest-quality patient care, ASCO works to conquer cancer and create a world where cancer is prevented or cured, and every survivor is healthy. ASCO is supported by its affiliate organization, the Conquer Cancer Foundation. Learn more at www.ASCO.org, explore patient education resources at www.Cancer.Net, and follow us on Facebook, Twitter, LinkedIn, and YouTube.